Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Diabetes Prevention Clinical Trials

A listing of Diabetes Prevention medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (28) clinical trials

Have you been diagnosed with Prediabetes or Type II Diabetes? Are you treating your condition with diet or metformin alone? A clinical research study is being conducted by Dr. John E. Ervin at The Center for Pharmaceutical Research. The outpatient study is testing an investigational weight loss device intended to ...

Phase N/A

The overall study will consist of two parts conducted in tandem: This Pilot Study is a 3-month pilot RCT study to test the feasibility of the Sweetch app in combination with a digital body weight scale (DBWS), with both groups receiving usual care for prediabetes.

Phase N/A

T1 Diabetes Hypoglycemia Prevention Pilot

This is a single center 12-week Pilot trial with one arm. Subjects will serve as their own controls. The study will include usual care patients on MDI (multiple daily injections) or CSII (continuous subcutaneous insulin infusion) with the additional use of the Vigilant ™ Diabetes Management System. There will be ...

Phase N/A

A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion

This is a pilot study to determine whether a large-scale randomized trial is feasible. The pilot study will test if the Vigilant Diabetes Management System is effective in adults with T-I Diabetes in preventing nocturnal hypoglycemia, improving moderate hypoglycemia, improving diabetes quality of life and in reducing fear of hypoglycemia. ...

Phase N/A

PERFECT Project - Part 1 - Study 3

The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) post-prandial blood glucose, insulin and appetite for two hours, and 2) food intake two hours following consumption of pulse products. The investigators hypothesize that bagels containing pulse ingredients will lead to lower blood glucose, ...

Phase N/A

PowerUp for Health: A Diabetes Prevention Program for Men

During year one, the multi-disciplinary research team will work closely with the expert and community Advisory Panel and consultants to adapt the standard NDPP curriculum in order to promote increased engagement of men. "Engagement" is defined in this proposal to include recruitment, group participation and retention in the 16-week program. ...

Phase N/A

Pathway to Prevention Study

The Pathway to Prevention Study is conducted in two parts: Screening Monitoring (annual and semi-annual depending on risk) In Screening , a simple blood test is done to screen for the presence of diabetes-related biochemical autoantibodies (GAD, IA-2A, mIAA). Islet cell autoantibodies (ICA) and ZnT8A are also measured in individuals ...

Phase N/A

Prevention Strategies for Adolescents at Risk of Diabetes

Data will be collected in 5 European Commission countries (500 adolescents in total). A range of biological and lifestyle measures will be collected in order to investigate the adolescent's lifestyle and will include body weight and other anthropometric measurements, blood pressure, blood capillary sample, self-reported physical activity, sedentary behaviour and ...

Phase N/A

Integrating Community Health Workers to Improve Diabetes Prevention

This population based trial aims to understand the impact of peer health interventions on panels of patients in a real clinic environment Investigators will conduct a cluster-randomized trial to test the impact of peer health coaches on prediabetic patients cared for by patient-centered medical home model (PCMH) teams to Reduce ...

Phase N/A

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

After complete islet graft loss is determined, patient's maintenance immunosuppression (i.e. sirolimus and tacrolimus) will be discontinued and they will be placed on Myfortic monotherapy for 2 years thereafter. After completion of two years of Myfortic maintenance monotherapy, it will be weaned and subjects will be monitored over the subsequent ...

Phase N/A